Eversept Partners, LP Alector, Inc. Transaction History
Eversept Partners, LP
- $991 Million
- Q4 2024
A detailed history of Eversept Partners, LP transactions in Alector, Inc. stock. As of the latest transaction made, Eversept Partners, LP holds 200,095 shares of ALEC stock, worth $340,161. This represents 0.04% of its overall portfolio holdings.
Number of Shares
200,095
Previous 332,756
39.87%
Holding current value
$340,161
Previous $1.55 Million
75.66%
% of portfolio
0.04%
Previous 0.12%
Shares
4 transactions
Others Institutions Holding ALEC
# of Institutions
156Shares Held
50MCall Options Held
20.9KPut Options Held
26.1K-
Ra Capital Management, L.P. Boston, MA9.7MShares$16.5 Million0.3% of portfolio
-
Black Rock Inc. New York, NY9.1MShares$15.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.62MShares$9.55 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.91MShares$3.25 Million0.0% of portfolio
-
State Street Corp Boston, MA1.85MShares$3.14 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $140M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...